Tessera Therapeutics Highlights Advancements Across its Gene Writing™ and Delivery Platforms
RNA Gene Writing™ platform demonstrates clinically relevant levels of in vivo rewriting in the genome of liver cells of non-human primates following a single administration RNA Gene Writing™ platform generates tumor-clearing CAR T cells by all-RNA delivery RNA Gene Writers™ demonstrate programmable writing to facilitate targeted DNA integration and ability to make small and large changes at the same time in human cells DNA Gene Writing™ platform promotes sustained and high le